Consumer Goods & Retail Global On demand · 24-48h

Global Pet DNA Kit Market Strategic Research Report

Global Pet DNA Kit Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pet DNA Kit Market
$2462025
11%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Cat Kit, Dog Kit, Others

By Application: Online Sales, Offline Sales

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Embark Veterinary, Mars Petcare (Wisdom Panel), Orivet Genetic Pet Care, DNA My Dog (Canadian Dog Group), Ancestry, TellmeGen (Koko Genetics), Meidike Gene, Basepaws, EasyDNA, VetGen, Royal Canin, Thermo Fisher Scientific

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$246
Million USD
Forecast CAGR
11%
2025-2032
Forecast 2032
$510.7
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Pet DNA Kit market size is predicted to grow from US$ 246 million in 2025 to US$ 504 million in 2032; it is expected to grow at a CAGR of 11.0% from 2026 to 2032.

A pet DNA kit is a tool used to test the genetic information of pets (such as cats and dogs). By collecting saliva or oral cell samples, it analyzes the pet's breed composition, genetic disease risks, health characteristics, and behavioral tendencies. These products typically include a sampling swab, preservation fluid, and mailing packaging. Users simply complete the sample at home and mail it back to the laboratory to receive a detailed genetic test report.

In 2024, the global production of pet DNA kits reached 2.8 million units, with an average selling price of US$90 per unit.

The pet DNA kit market has experienced rapid growth in recent years, with dog DNA testing leading the market, followed by cat DNA testing. Key drivers include the increasing humanization of pets, rising demand for genetic disease screening, and the standardization of purebred pet breeding. North America accounts for over 50% of the market, with emerging markets such as China experiencing significant growth. International brands such as Embark and Wisdom Panel have dominated the high-end market with their technological advantages, while Chinese manufacturers are rapidly expanding through cost-effective strategies. In the future, with the decreasing cost of whole-genome sequencing technology and the rise of value-added services such as pet insurance, the market is expected to maintain annual growth rates exceeding 10%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pet DNA Kit market?

What factors are driving Pet DNA Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pet DNA Kit market opportunities vary by end market size?

How does Pet DNA Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Pet DNA Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Cat Kit
  • Dog Kit
  • Others

Segment by Application

  • Online Sales
  • Offline Sales

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pet DNA Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Online Sales, Offline Sales evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pet DNA Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 11%
Regional growth momentum
Market share by segment
Key metrics
Base value
$246
2025
Forecast
$510.7
2032
CAGR
11%
2025–2032
Regionen
5
global
Key companies
Embark VeterinaryMars Petcare (Wisdom Panel)Orivet Genetic Pet CareDNA My Dog (Canadian Dog Group)AncestryTellmeGen (Koko Genetics)Meidike GeneBasepaws
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Cat KitDog KitOthers
By Application
Online SalesOffline Sales

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Cat Kit
  • 3.1.3 Dog Kit
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Online Sales
  • 4.1.3 Offline Sales
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Embark Veterinary
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Mars Petcare (Wisdom Panel)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Orivet Genetic Pet Care
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 DNA My Dog (Canadian Dog Group)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Ancestry
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 TellmeGen (Koko Genetics)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Meidike Gene
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Basepaws
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 EasyDNA
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 VetGen
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Royal Canin
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Thermo Fisher Scientific
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Pet DNA Kit market?
The global Pet DNA Kit market is estimated at US$ 246 million in 2025 (base year) and is projected to reach US$ 504 million by 2032.
How fast is the Pet DNA Kit market expected to grow?
The market is expected to grow at a CAGR of 11.0% from 2026 to 2032, expanding from US$ 246 million in 2025 to US$ 504 million in 2032, roughly 2.0 times its base-year value.
What does the Pet DNA Kit market cover?
A pet DNA kit is a tool used to test the genetic information of pets (such as cats and dogs). By collecting saliva or oral cell samples, it analyzes the pet's breed composition, genetic disease risks, health characteristics, and behavioral tendencies. These products typically include a sampling swab, preservation fluid, and mailing packaging.
How is the Pet DNA Kit market segmented by type?
By type, the market is segmented into Cat Kit, Dog Kit and Others.
What are the key applications of Pet DNA Kit?
Key applications covered include Online Sales and Offline Sales.
Which companies are profiled in the Pet DNA Kit market report?
Key players profiled include Embark Veterinary, Mars Petcare (Wisdom Panel), Orivet Genetic Pet Care, DNA My Dog (Canadian Dog Group), Ancestry, TellmeGen (Koko Genetics), Meidike Gene and Basepaws, among 12 companies covered in total.
What geographies does the Pet DNA Kit market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Pet DNA Kit?
What factors are driving Pet DNA Kit market growth, globally and by region?
Who should buy the Pet DNA Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Online Sales and Offline Sales, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pet DNA Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.